Pharmaceutical companies competing to develop coronavirus vaccines are already working behind the scenes to build the supply chains necessary to deliver their drugs to billions of people as quickly as possible. To meet global demand once a vaccine is approved, a complicated and high-risk supply chain would be put in …
Read More »
Johnson & Johnson, like all drug makers in the COVID-19 vaccine race, hopes to muster enough manufacturing capacity to rapidly scale production of its vaccine. Now, for a sum of nearly half a trillion dollars, J&J is ready to put his money where his mouth is. J&J and Maryland-based CDMO …
Read More »
It is not an understatement to say that the hopes of the entire nation are focused on what is happening in a Maryland laboratory: first step in manufacturing a potential coronavirus vaccine. Sean Kirk, Executive Vice President of Emergent BioSolutions, explained to correspondent Martha Teichner how a bioreactor is used …
Read More »